Literature DB >> 31713550

Sustained delivery of growth factors with high loading efficiency in a layer by layer assembly.

Febriyani F R Damanik1, Marzia Brunelli, Laura Pastorino, Carmelina Ruggiero, Clemens van Blitterswijk, Joris Rotmans, Lorenzo Moroni.   

Abstract

Layer by layer (LBL) assembly has garnered considerable interest due to its ability to generate multifunctional films with high tunability and versatility in terms of substrates and polyelectrolytes, allowing the option to use complex devices and drugs. Polyelectrolytes, such as growth factors (GFs), are essential, but costly, delicate, biological molecules that have been used in various tissue regeneration applications. For this reason, the controlled drug delivery of efficiently loaded GFs via LBL assembly (GF-LBL) can contribute to the establishment of cost-effective biologically triggered biomedical applications. We have developed an LBL method to load GFs (specifically, transforming growth factor beta 1, platelet-derived growth factor ββ, and insulin growth factor 1), with up to 90% efficiency approximately, by gas plasma surface activation and tuning the pH to increase the ionic strength of polyelectrolytes. Poly(styrenesulfonate) (PSS) and poly(ethyleneimine) (PEI) have been used to provide the initial necessary charge for multilayer build-up. Heparin and dextran sulphate have been investigated as counter polyelectrolytes to enhance the activity of GFs by protecting their ligands, where heparin resulted in the highest achievable loading efficiency for all GFs. Oxygen gas plasma and acidic pH levels also resulted in a significant increase in GF loading efficiency. The three GFs were released by diffusion and erosion in a controlled manner over lengthy time scales and the bioactivity was maintained for up to 14 days. When tested as implants in vitro, GF-LBL constructs increased fibroblast proliferation, influenced cell morphology and migration, and enhanced myofibroblast differentiation, indicating that the biological functionalities of the GFs were preserved. In conclusion, this developed LBL assembly method can provide a simple drug delivery system, which may yield more effective applications for tissue regeneration as well as biomedical sciences at large.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31713550     DOI: 10.1039/c9bm00979e

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  6 in total

1.  Long-Term Controlled Growth Factor Release Using Layer-by-Layer Assembly for the Development of In Vivo Tissue-Engineered Blood Vessels.

Authors:  Febriyani F R Damanik; Carolien T Rothuizen; Reshma Lalai; Sandhia Khoenkhoen; Clemens van Blitterswijk; Joris I Rotmans; Lorenzo Moroni
Journal:  ACS Appl Mater Interfaces       Date:  2022-06-13       Impact factor: 10.383

Review 2.  The Auxiliary Role of Heparin in Bone Regeneration and its Application in Bone Substitute Materials.

Authors:  Jing Wang; Lan Xiao; Weiqun Wang; Dingmei Zhang; Yaping Ma; Yi Zhang; Xin Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-12

Review 3.  Supramolecular Hydrogels for Protein Delivery in Tissue Engineering.

Authors:  Yaqi Lyu; Helena S Azevedo
Journal:  Molecules       Date:  2021-02-07       Impact factor: 4.411

Review 4.  The Potential of Polyelectrolyte Multilayer Films as Drug Delivery Materials.

Authors:  Joanna Potaś; Katarzyna Winnicka
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

Review 5.  Tooth Formation: Are the Hardest Tissues of Human Body Hard to Regenerate?

Authors:  Juliana Baranova; Dominik Büchner; Werner Götz; Margit Schulze; Edda Tobiasch
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

6.  Advanced PLGA hybrid scaffold with a bioactive PDRN/BMP2 nanocomplex for angiogenesis and bone regeneration using human fetal MSCs.

Authors:  Da-Seul Kim; Jun-Kyu Lee; Jun Hyuk Kim; Jaemin Lee; Dong Seon Kim; Sanghyun An; Sung-Bin Park; Tae-Hyung Kim; Jong Seop Rim; Soonchul Lee; Dong Keun Han
Journal:  Sci Adv       Date:  2021-12-08       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.